Diabetes status, duration, and risk of dementia among ischemic stroke patients.

IF 7.6 1区 医学 Q1 CLINICAL NEUROLOGY Alzheimer's Research & Therapy Pub Date : 2025-03-08 DOI:10.1186/s13195-025-01708-8
Jonguk Kim, Kyung-Do Han, Jeong-Yoon Lee, Ye Seul Yang, Dae Young Cheon, Jae-Jun Lee, Minwoo Lee
{"title":"Diabetes status, duration, and risk of dementia among ischemic stroke patients.","authors":"Jonguk Kim, Kyung-Do Han, Jeong-Yoon Lee, Ye Seul Yang, Dae Young Cheon, Jae-Jun Lee, Minwoo Lee","doi":"10.1186/s13195-025-01708-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The influence of duration of type 2 diabetes mellitus (T2DM) on the likelihood of developing new-onset dementia in post-stroke population is not well understood. Therefore, we aimed to clarify the relationship between the duration of T2DM and the risk of developing dementia in the post-stroke population.</p><p><strong>Methods: </strong>Leveraging the Korean National Health Insurance Database, this study included 118,790 individuals with a history of stroke but no previous dementia diagnosis. We classified diabetes status into five categories: normoglycemia, impaired fasting glucose (IFG), newly diagnosed T2DM, and established T2DM with durations of less than 5 years and 5 years or more. The primary endpoint was the incidence of all-cause dementia.</p><p><strong>Results: </strong>Among 118,790 participants (average age 64.26 ± 9.95 years, 48% male), 16.7% developed dementia during an average follow-up of 7.3 ± 2.3 years. Participants with a history of T2DM for less than five years at cohort entry had a 26.7% higher risk of developing all-cause dementia compared to those with normoglycemia. Those with T2DM for five years or longer had a 46.7% increased risk, with an adjusted hazard ratio (aHR) of 1.466 (95% confidence interval [CI], 1.408-1.527). Specifically, the risk of developing Alzheimer's disease (AD) and vascular dementia (VaD) rose by 43.4% and 51.4%, respectively, for individuals with T2DM lasting more than five years (aHR 1.434, 95% CI 1.366-1.505; aHR 1.514, 95% CI 1.365-1.679, respectively).</p><p><strong>Conclusions: </strong>Our findings demonstrated a significant association between an extended duration of T2DM and an increased risk of developing all-cause dementia, including AD and VaD in post-stroke population. These results emphasize proactive dementia prevention approaches in stroke survivors, particularly those with longstanding T2DM.</p>","PeriodicalId":7516,"journal":{"name":"Alzheimer's Research & Therapy","volume":"17 1","pages":"58"},"PeriodicalIF":7.6000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11889840/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's Research & Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13195-025-01708-8","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The influence of duration of type 2 diabetes mellitus (T2DM) on the likelihood of developing new-onset dementia in post-stroke population is not well understood. Therefore, we aimed to clarify the relationship between the duration of T2DM and the risk of developing dementia in the post-stroke population.

Methods: Leveraging the Korean National Health Insurance Database, this study included 118,790 individuals with a history of stroke but no previous dementia diagnosis. We classified diabetes status into five categories: normoglycemia, impaired fasting glucose (IFG), newly diagnosed T2DM, and established T2DM with durations of less than 5 years and 5 years or more. The primary endpoint was the incidence of all-cause dementia.

Results: Among 118,790 participants (average age 64.26 ± 9.95 years, 48% male), 16.7% developed dementia during an average follow-up of 7.3 ± 2.3 years. Participants with a history of T2DM for less than five years at cohort entry had a 26.7% higher risk of developing all-cause dementia compared to those with normoglycemia. Those with T2DM for five years or longer had a 46.7% increased risk, with an adjusted hazard ratio (aHR) of 1.466 (95% confidence interval [CI], 1.408-1.527). Specifically, the risk of developing Alzheimer's disease (AD) and vascular dementia (VaD) rose by 43.4% and 51.4%, respectively, for individuals with T2DM lasting more than five years (aHR 1.434, 95% CI 1.366-1.505; aHR 1.514, 95% CI 1.365-1.679, respectively).

Conclusions: Our findings demonstrated a significant association between an extended duration of T2DM and an increased risk of developing all-cause dementia, including AD and VaD in post-stroke population. These results emphasize proactive dementia prevention approaches in stroke survivors, particularly those with longstanding T2DM.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
缺血性脑卒中患者的糖尿病状况、病程和痴呆风险
背景:2型糖尿病(T2DM)持续时间对卒中后人群新发痴呆可能性的影响尚不十分清楚。因此,我们旨在阐明 T2DM 持续时间与中风后人群痴呆症发病风险之间的关系:本研究利用韩国国民健康保险数据库,纳入了 118,790 名有脑卒中病史但既往未确诊痴呆的患者。我们将糖尿病状态分为五类:血糖正常、空腹血糖受损(IFG)、新诊断的 T2DM、病程少于 5 年和 5 年或以上的已确诊 T2DM。主要终点是全因痴呆症的发病率:在 118,790 名参与者(平均年龄为 64.26 ± 9.95 岁,48% 为男性)中,16.7% 的人在平均 7.3 ± 2.3 年的随访期间患上了痴呆症。与血糖正常者相比,加入队列时患 T2DM 病史不足 5 年的参与者患全因痴呆症的风险高出 26.7%。T2DM病史在5年或5年以上的患者罹患全因痴呆症的风险增加了46.7%,调整后的危险比(aHR)为1.466(95%置信区间[CI],1.408-1.527)。具体而言,T2DM持续时间超过5年的患者罹患阿尔茨海默病(AD)和血管性痴呆(VaD)的风险分别增加了43.4%和51.4%(aHR 1.434,95% CI 1.366-1.505;aHR 1.514,95% CI 1.365-1.679):我们的研究结果表明,在脑卒中后人群中,T2DM持续时间延长与罹患全因痴呆(包括注意力缺失症和失智症)的风险增加之间存在明显关联。这些结果强调了对脑卒中幸存者,尤其是长期患有 T2DM 的幸存者采取积极的痴呆预防方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy 医学-神经病学
CiteScore
13.10
自引率
3.30%
发文量
172
审稿时长
>12 weeks
期刊介绍: Alzheimer's Research & Therapy is an international peer-reviewed journal that focuses on translational research into Alzheimer's disease and other neurodegenerative diseases. It publishes open-access basic research, clinical trials, drug discovery and development studies, and epidemiologic studies. The journal also includes reviews, viewpoints, commentaries, debates, and reports. All articles published in Alzheimer's Research & Therapy are included in several reputable databases such as CAS, Current contents, DOAJ, Embase, Journal Citation Reports/Science Edition, MEDLINE, PubMed, PubMed Central, Science Citation Index Expanded (Web of Science) and Scopus.
期刊最新文献
The impact of socioeconomic status and lifestyle on cognitive aging and brain health: results from the LIFE-Adult-Study. Selective reduction of ADAM10 in brain and cerebrospinal fluid of Alzheimer's disease patients. Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms. Interactive effects of telomere length and genetic variants on Alzheimer disease risk across multiple ancestral populations. Real-world implementation of lecanemab and donanemab in an Italian memory center: a 1-year experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1